Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Intangibles (2024 - 2025)

Historic Intangibles for Madrigal Pharmaceuticals (MDGL) over the last 2 years, with Q3 2025 value amounting to $7.5 million.

  • Madrigal Pharmaceuticals' Intangibles rose 5515.67% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 5515.67%. This contributed to the annual value of $4.7 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Intangibles of $7.5 million as of Q3 2025, which was up 5515.67% from $4.5 million recorded in Q2 2025.
  • Madrigal Pharmaceuticals' Intangibles' 5-year high stood at $7.5 million during Q3 2025, with a 5-year trough of $4.5 million in Q2 2025.